Table 3 The summary of the reported cases of aortic dissection in patients with primary aldosteronism
Case | Study | Age/Sex | Age of diagnostic | Serum potassium | AD type | PA | PA Treatment before AD | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
HTN | PA | AD | (mmol/l) | (D/S) | Type | Side | Size (cm) | ||||
1 | Shimizu et al., 1983 [13] | 37/F | 30 | 34 | 37 | 2.7 | I/A | Adrenal adenoma | Right | 1.5 | Yes, spironolactone for 1 year |
2 | Lam et al., 1999 [14] | 39/M | 39 | 39 | 43 | 2.7 | I/A | Nodular cortical hyperplasia | Left | 1.4 | No |
3 | Safi et al., 1999 [15] | 39/F | 15 | 39 | 39 | 2.5–3.0 | II/A | Adrenal adenoma | Left | 1 | No |
4 | Ahmed et al., 2007 [16] | 48/M | – | 48 | 48 | 3.2 | III/B | – | Left | 2 | Yes, aldosterone antagonist for 1 month |
5 | Harvey et al., 2010 [17] | 39/M | 29 | 39 | 39 | 2.5 | III/B | Adrenal adenoma | Left | – | Yes, aldosterone antagonist for 6 months |
6 | Hirai et al., 2010 [18] | 38/M | – | 38 | 38 | 1.9 | III/B | Adrenal adenoma | Left | 1 | No |
7 | Shahrrava et al., 2016 [19] | 24/M | 10 | 18 | 10 | – | – | Glucocorticoid remediable aldosteronism | – | – | No |
8 | Our case | 56/F | 42 | 56 | 48 | 2.4 | III/B | Adrenal adenoma | Left | 3 | No |